Use of vascular endothelial growth factor, placenta growth...

Details Use of vascular endothelial growth factor, placenta growth... Use of vascular endothelial growth factor, placenta growth...

2005-08-16

2005-08-16

Andres, Janet (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C530S399000, C530S350000

Reexamination Certificate

active

06930089

ABSTRACT:
Vascular endothelial growth factor, placenta growth factor or combinations of both including heteodimers are useful in the treatment or prevention of stroke or ischemic diseases in mammals.

REFERENCES:
patent: 2 332 373 (1999-06-01), None
patent: WO 97/14307 (1997-04-01), None
patent: WO 98/07832 (1998-02-01), None
patent: WO 98/493 (1998-11-01), None
patent: WO 99/40197 (1999-08-01), None
Domenico Maglione, Valente Guerriero, Giuseppe Viglieto, Pasquale DLLI-BOVI and M. Graziella Persico, Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor, Proc. Natl. Acad. Sci. USA, vol. 88, pp. 9267-9271, Oct., 1991 Biochemistry.
Frelin, “VEGF: A mediation of hypoxic angiogenesis”, Medicine Sciences, vol. 13, no. 6-7, 1997, pp 886-892.

Affiliated with

Also associated with

Rating

Use of vascular endothelial growth factor, placenta growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of vascular endothelial growth factor, placenta growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of vascular endothelial growth factor, placenta growth... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3472510